Rl. Stariha et al., ROLE OF EXTRACELLULAR SIGNAL-REGULATED PROTEIN-KINASE-1 AND PROTEIN-KINASE-2 IN OLIGODENDROGLIAL PROCESS EXTENSION, Journal of neurochemistry, 68(3), 1997, pp. 945-953
The relationship between extracellular signal-regulated protein kinase
(ERK) activation and process extension in cultured bovine oligodendro
cytes (OLGs) was investigated, Process extension was induced through t
he exposure of cultured OLGs to phorbol 12-myristate 13-acetate (PMA),
an activator of protein kinase C (PKC), for various intervals. During
the isolation of these OLGs from bovine brain, the original processes
were lost, Therefore, any reinitiation of process extension via PMA s
timulation was easily discernible through morphological monitoring, It
was found that exposure of OLGs to PMA for 10 min was enough to induc
e OLG process extension 24-72 h later, Furthermore, this extension was
still evident at least 1 week after the initial PMA stimulation, indi
cating that OLGs do not need continuous PKC activation to sustain proc
ess extension. Control and PMA-stimulated OLGs were also subjected to
immunocytochemistry using an anti-ERK antibody selective for the mitog
en-activated protein kinases p42 Erk2 (ERK2) and p44 Erk1 (ERK1) isofo
rms. ERK immunoreactivity in the nucleus was evident after PMA stimula
tion of OLGs but not in control OLGs. In parallel experiments, the con
trol and PMA-stimulated OLGs were purified by Mono Q fractionation and
subjected to ERK phosphotransferase assays using [gamma-P-32]ATP and
either myelin basic protein (MBP) or a synthetic peptide substrate bas
ed on the Thr(97) phosphorylation site in MBP. These assays indicated
that in PMA-treated OLGs, ERK activation was at least 12-fold higher t
han in control OLGs. Anti-ERK and anti-phosphotyrosine western blots o
f the assay fractions verified an enhanced phosphorylation of ERK1 and
ERK2 in PMA-treated fractions relative to control fractions. When OLG
s were pretreated for 15 min with the ERK kinase (MEK) inhibitor PD 09
8059 before PMA stimulation, they exhibited a 67% decrease in ERK acti
vation as compared with cells treated with PMA alone. Furthermore, the
se MEK inhibitor-pretreated cells were still viable but showed no proc
ess extensions up to 1 week later. Therefore, we propose that a thresh
old level of ERK activity is required for the initiation of OLG proces
s extension.